The Independent on MSN7 个月
Capita ‘on track’ with £160m cost-cutting plan as it swings to profit
Capita has swung to a profit as the outsourcing giant said it is “on track” with cost-cutting plans. The major contractor for ...
pharmaphorum9 天
After surging on lung cancer data, Ignyta looks to raise $160m
The drug was also granted a fast-track Priority Medicines (PRIME) designation in Europe this week, adding to its FDA Breakthrough status granted in May this year. Entrectinib is currently in a ...